ArticleFrontiers in immunology2022

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.

Kai Jakobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.